Project Grant R01NS134799

Award Date 1/1/25
Completion Date 12/31/29
Dollars Obligated $404K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Boston, MA 02129, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will fund research at the Augusta University Research Institute, Inc. (doing business as Georgia Health Sciences) to investigate the mechanisms linking traumatic brain injury (TBI) to subsequent neurodegeneration and dementia. The $1,975,262 award will support a 3-year...
This $238,500 federal Project Grant award was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award supports research to investigate the neurobehavioral and pathophysiological effects of traumatic brain injury (TBI) in spontaneously hypertensive rats. The project aims to advance understanding of TBI mechanisms and potential treatments, which is...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) is funding research at Case Western Reserve University to investigate the link between traumatic brain injury (TBI) and the increased risk of Alzheimer's disease (AD). The $102,948 award, effective from December 1, 2024 to August 31, 2027, supports an interdisciplinary project that aims to assess...
This $556,661 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will fund research to investigate the role of thalamic microglia in cognitive impairment following cortical injuries, such as those caused by traumatic brain injury (TBI). The project aims to elucidate the changes in thalamic microglia after cortical injuries, demonstrate the restorative...
The National Institutes of Health's National Institute on Aging awarded a $2,366,184 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital, to support research into the mechanisms of circadian and synaptic dysfunction after repetitive mild traumatic brain injury. The three-year award, made on June 1, 2022 under the Aging Research program (CFDA 93.866), will fund work by Drs. Whalen and Lipton to define how interleukin-1 receptor 1-mediated...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), supports research to investigate the role of the skull bone marrow niche in post-stroke inflammation and recovery. The $798,848 award, running from March 1, 2025 to February 28, 2029, will fund research to examine the information transfer between the central nervous system and the skull...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $230,580.00 to support research aimed at understanding the mechanisms underlying brain-immune interactions at the blood-brain barrier. The overarching goal is to generate novel targets for immunotherapy in neuroinflammatory conditions. The award recipient, Brigham &...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $2,036,299.00 to the University of Pittsburgh to investigate cognitive and affective deficits following traumatic brain injury (TBI). The goal is to develop a flexible multi-modal microelectrode array to chronically monitor striatal dopamine, glutamate, and medium spiny neuron activity in...
This Cooperative Agreement award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will provide $1,122,294 to Trustees of Boston University (Boston University Medical Campus) to study the relationship between traumatic brain injury (TBI), repetitive head impacts (RHI), and neurodegenerative conditions such as Alzheimer's disease, Alzheimer's-related dementias, and...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $236,850.00 to Rosalind Franklin University of Medicine & Science to investigate the role of NEP-like enzymes in the acute pathology and long-term effects of traumatic brain injury (TBI), including the development of dementia. The research aims to determine the importance of these enzymes in clearing amyloid-beta, a key pathological hallmark shared between TBI and Alzheimer's disease. The...

This Project Grant award of $404,100.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to investigate mechanisms of chronic blood-brain barrier (BBB) dysfunction after traumatic brain injury (TBI). The central hypothesis is that persistent activation of the RIPK1-RIPK3-IL-1β signaling pathway drives post-traumatic angiogenesis and chronic BBB damage, perpetuating neurodegeneration and cognitive deficits. The research aims to identify this endothelial pathway, test whether inhibiting it can repair established BBB damage, and define the mechanisms by which IL-1β activation drives chronic BBB damage after TBI. The grant recipient, the General Hospital Corporation's Research Management Division (doing business as Massachusetts General Hospital), will leverage its expertise in biomedical research and partnerships to advance understanding of how TBI leads to dementia and other neurodegenerative diseases, with the goal of developing new therapies.

Generated 4/8/25, 4:20 AM